{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:19Z","timestamp":1786982179203,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12012-024-09923-9","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T06:02:24Z","timestamp":1728021744000},"page":"1428-1438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in Factors Affecting ALDH2 Activity and its Mechanisms"],"prefix":"10.1007","volume":"24","author":[{"given":"Yun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"1","key":"9923_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1265\/jjh.71.55","volume":"71","author":"A Matsumoto","year":"2016","unstructured":"Matsumoto, A. (2016). Fundamental properties of aldehyde dehydrogenase 2 (ALDH2) and the importance of the ALDH2 polymorphism. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 71(1), 55\u201368.","journal-title":"Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene)"},{"issue":"12","key":"9923_CR2","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo, X., Disatnik, M. H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X. (2013). Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. Journal of Clinical Investigation, 123(12), 5371\u20135388.","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"9923_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1172\/JCI122064","volume":"129","author":"S Zhong","year":"2019","unstructured":"Zhong, S., Li, L., Zhang, Y. L., Zhang, L., Lu, J., Guo, S., Liang, N., Ge, J., Zhu, M., Tao, Y., Wu, Y. C., & Yin, H. (2019). Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation. Journal of Clinical Investigation, 129(1), 252\u2013267.","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"9923_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang, H., & Fu, L. (2021). The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment. Acta Pharmaceutica Sinica B, 11(6), 1400\u20131411.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"9923_CR5","doi-asserted-by":"publisher","first-page":"255ra130","DOI":"10.1126\/scitranslmed.3009027","volume":"6","author":"AD Ebert","year":"2014","unstructured":"Ebert, A. D., Kodo, K., Liang, P., Wu, H., Huber, B. C., Riegler, J., Churko, J., Lee, J., de Almeida, P., Lan, F., Diecke, S., Burridge, P. W., Gold, J. D., Mochly-Rosen, D., & Wu, J. C. (2014). Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase genetic polymorphism using a human induced pluripotent stem cell model system. Science Translational Medicine, 6, 255ra130.","journal-title":"Science Translational Medicine"},{"issue":"2","key":"9923_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1172\/JCI26564","volume":"116","author":"Y Li","year":"2006","unstructured":"Li, Y., Zhang, D., Jin, W., Shao, C., Yan, P., Xu, C., Sheng, H., Liu, Y., Yu, J., Xie, Y., Zhao, Y., Lu, D., Nebert, D. W., Harrison, D. C., Huang, W., & Jin, L. (2006). Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. Journal of Clinical Investigation, 116(2), 506\u2013511.","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"9923_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/JU.0000000000002682","volume":"208","author":"DR Greenberg","year":"2022","unstructured":"Greenberg, D. R., Bhambhvani, H. P., Basran, S. S., Salazar, B. P., Rios, L. C., Li, S. J., Chen, C. H., Mochly-Rosen, D., & Eisenberg, M. L. (2022). ALDH2 expression, alcohol intake and semen parameters among East Asian Men. Journal of Urology, 208(2), 406\u2013413.","journal-title":"Journal of Urology"},{"issue":"1","key":"9923_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/acer.12215","volume":"38","author":"CL Lai","year":"2014","unstructured":"Lai, C. L., Yao, C. T., Chau, G. Y., Yang, L. F., Kuo, T. Y., Chiang, C. P., & Yin, S. J. (2014). Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver. Clinical and Experimental Research, 38(1), 44\u201350.","journal-title":"Clinical and Experimental Research"},{"issue":"7","key":"9923_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41569-023-00839-5","volume":"20","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Guo, Y., Zhao, X., Pang, J., Pan, C., Wang, J., Wei, S., Yu, X., Zhang, C., Chen, Y., Yin, H., & Xu, F. (2023). The role of aldehyde dehydrogenase 2 in cardiovascular disease. Nature Reviews Cardiology, 20(7), 495\u2013509.","journal-title":"Nature Reviews Cardiology"},{"issue":"8","key":"9923_CR10","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., Commodore-Mensah, Y., Elkind, M. S. V., Evenson, K. R., Eze-Nliam, C., Fugar, S., Generoso, G., Heard, D. G., Hiremath, S., Ho, J. E., \u2026 Martin, S. S. (2023). Heart disease and stroke statistics-2023 update: A report from the American Heart Association. Circulation, 147(8), e93\u2013e621.","journal-title":"Circulation"},{"issue":"26","key":"9923_CR11","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/ehaa444","volume":"41","author":"F Bartoli-Leonard","year":"2020","unstructured":"Bartoli-Leonard, F., Saddic, L., & Aikawa, E. (2020). Double-edged sword of ALDH2 mutations: one polymorphism can both benefit and harm the cardiovascular system. European Heart Journal, 41(26), 2453\u20132455.","journal-title":"European Heart Journal"},{"issue":"1","key":"9923_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee, J. M., Hammaren, H. M., Savitski, M. M., & Baek, S. H. (2023). Control of protein stability by post-translational modifications. Nature Communications, 14(1), 201.","journal-title":"Nature Communications"},{"issue":"1","key":"9923_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.gene.2016.06.016","volume":"590","author":"SB Scruggs","year":"2016","unstructured":"Scruggs, S. B., Wang, D., & Ping, P. (2016). PRKCE gene encoding protein kinase C-epsilon-dual roles at sarcomeres and mitochondria in cardiomyocytes. Gene, 590(1), 90\u201396.","journal-title":"Gene"},{"issue":"5895","key":"9923_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1126\/science.1158554","volume":"321","author":"CH Chen","year":"2008","unstructured":"Chen, C. H., Budas, G. R., Churchill, E. N., Disatnik, M. H., Hurley, T. D., & Mochly-Rosen, D. (2008). Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science, 321(5895), 1493\u20131495.","journal-title":"Science"},{"issue":"1","key":"9923_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41392-020-0171-5","volume":"5","author":"S Wang","year":"2020","unstructured":"Wang, S., Wang, L., Qin, X., Turdi, S., Sun, D., Culver, B., Reiter, R. J., Wang, X., Zhou, H., & Ren, J. (2020). ALDH2 contributes to melatonin-induced protection against APP\/PS1 mutation-prompted cardiac anomalies through cGAS-STING-TBK1-mediated regulation of mitophagy. Signal Transduction and Targeted Therapy if, 5(1), 119.","journal-title":"Signal Transduction and Targeted Therapy if"},{"key":"9923_CR16","doi-asserted-by":"publisher","first-page":"3481623","DOI":"10.1155\/2020\/3481623","volume":"2020","author":"E Ji","year":"2020","unstructured":"Ji, E., Jiao, T., Shen, Y., Xu, Y., Sun, Y., Cai, Z., Zhang, Q., & Li, J. (2020). Molecular mechanism of HSF1-upregulated ALDH2 by PKC in ameliorating pressure overload-induced heart failure in mice. BioMed Research International, 2020, 3481623.","journal-title":"BioMed Research International"},{"key":"9923_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2012.03.017","volume":"55","author":"D Gong","year":"2013","unstructured":"Gong, D., Zhang, H., & Hu, S. (2013). Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. Journal of Molecular and Cellular Cardiology, 55, 58\u201363.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"8","key":"9923_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/1744666X.2021.1945443","volume":"17","author":"T Nguyen","year":"2021","unstructured":"Nguyen, T., Deenick, E. K., & Tangye, S. G. (2021). Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications. Expert Review of Clinical Immunology, 17(8), 905\u2013914.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"11","key":"9923_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/CIRCRESAHA.109.213645","volume":"106","author":"CJ Lagranha","year":"2010","unstructured":"Lagranha, C. J., Deschamps, A., Aponte, A., Steenbergen, C., & Murphy, E. (2010). Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circulation Research, 106(11), 1681\u20131691.","journal-title":"Circulation Research"},{"issue":"3","key":"9923_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2009.11.008","volume":"48","author":"KH Moon","year":"2010","unstructured":"Moon, K. H., Lee, Y. M., & Song, B. J. (2010). Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. Free Radical Biology and Medicine, 48(3), 391\u2013398.","journal-title":"Free Radical Biology and Medicine"},{"issue":"9","key":"9923_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-021-04134-4","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Wen, P., Luo, J., Ding, H., Cao, H., He, W., Zen, K., Zhou, Y., Yang, J., & Jiang, L. (2021). Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death & Disease, 12(9), 847.","journal-title":"Cell Death & Disease"},{"issue":"12","key":"9923_CR22","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.jprot.2011.05.013","volume":"74","author":"BJ Song","year":"2011","unstructured":"Song, B. J., Abdelmegeed, M. A., Yoo, S. H., Kim, B. J., Jo, S. A., Jo, I., & Moon, K. H. (2011). Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. Journal of Proteomics, 74(12), 2691\u20132702.","journal-title":"Journal of Proteomics"},{"issue":"3","key":"9923_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/acs.chemrestox.6b00315","volume":"30","author":"PS Harris","year":"2017","unstructured":"Harris, P. S., Gomez, J. D., Backos, D. S., & Fritz, K. S. (2017). Characterizing sirtuin 3 deacetylase affinity for aldehyde dehydrogenase 2. Chemical Research in Toxicology, 30(3), 785\u2013793.","journal-title":"Chemical Research in Toxicology"},{"issue":"8","key":"9923_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/embor.2011.121","volume":"12","author":"Z Lu","year":"2011","unstructured":"Lu, Z., Bourdi, M., Li, J. H., Aponte, A. M., Chen, Y., Lombard, D. B., Gucek, M., Pohl, L. R., & Sack, M. N. (2011). SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Reports, 12(8), 840\u2013846.","journal-title":"EMBO Reports"},{"issue":"2","key":"9923_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.febslet.2011.11.031","volume":"586","author":"L Xue","year":"2012","unstructured":"Xue, L., Xu, F., Meng, L., Wei, S., Wang, J., Hao, P., Bian, Y., Zhang, Y., & Chen, Y. (2012). Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation. FEBS Letters, 586(2), 137\u2013142.","journal-title":"FEBS Letters"},{"issue":"9","key":"9923_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCRESAHA.109.204974","volume":"105","author":"Z Lu","year":"2009","unstructured":"Lu, Z., Scott, I., Webster, B. R., & Sack, M. N. (2009). The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology. Circulation Research, 105(9), 830\u2013841.","journal-title":"Circulation Research"},{"issue":"1","key":"9923_CR27","first-page":"169","volume":"17","author":"R Gao","year":"2023","unstructured":"Gao, R., Lv, C., Qu, Y., Yang, H., Hao, C., Sun, X., Hu, X., Yang, Y., & Tang, Y. (2023). Remote Ischemic conditioning mediates cardio-protection after myocardial ischemia\/reperfusion injury by reducing 4-HNE levels and regulating autophagy via the ALDH2\/SIRT3\/HIF1alpha signaling pathway. Journal of Cardiovascular Translational Research, 17(1), 169\u2013182.","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"8","key":"9923_CR28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41401-021-00828-9","volume":"43","author":"S Zhao","year":"2022","unstructured":"Zhao, S., Song, T. Y., Wang, Z. Y., Gao, J., Cao, J. W., Hu, L. L., Huang, Z. R., Xie, L. P., & Ji, Y. (2022). S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3beta signaling. Acta Pharmacologica Sinica, 43(8), 1979\u20131988.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"27","key":"9923_CR29","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1016\/j.febslet.2005.09.082","volume":"579","author":"KH Moon","year":"2005","unstructured":"Moon, K. H., Kim, B. J., & Song, B. J. (2005). Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation. FEBS Letters, 579(27), 6115\u20136120.","journal-title":"FEBS Letters"},{"issue":"107","key":"9923_CR30","doi-asserted-by":"publisher","first-page":"107111","DOI":"10.1126\/scitranslmed.3002067","volume":"3","author":"L Sun","year":"2011","unstructured":"Sun, L., Ferreira, J. C., & Mochly-Rosen, D. (2011). ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Science Translational Medicine, 3(107), 107111.","journal-title":"Science Translational Medicine"},{"issue":"5","key":"9923_CR31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/hep.21372","volume":"44","author":"KH Moon","year":"2006","unstructured":"Moon, K. H., Hood, B. L., Kim, B. J., Hardwick, J. P., Conrads, T. P., Veenstra, T. D., & Song, B. J. (2006). Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology, 44(5), 1218\u20131230.","journal-title":"Hepatology"},{"issue":"1","key":"9923_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2012.72","volume":"20","author":"S Shaid","year":"2013","unstructured":"Shaid, S., Brandts, C. H., Serve, H., & Dikic, I. (2013). Ubiquitination and selective autophagy. Cell Death & Differentiation, 20(1), 21\u201330.","journal-title":"Cell Death & Differentiation"},{"issue":"11","key":"9923_CR33","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.3390\/ijms21114088","volume":"21","author":"H Gu","year":"2020","unstructured":"Gu, H., & Jan, F. B. (2020). Specificity in ubiquitination triggered by virus infection. International Journal of Molecular Sciences, 21(11), 4088.","journal-title":"International Journal of Molecular Sciences"},{"key":"9923_CR34","doi-asserted-by":"publisher","first-page":"goad006","DOI":"10.1093\/gastro\/goad006","volume":"11","author":"H Zhou","year":"2023","unstructured":"Zhou, H., Wan, S., Luo, Y., Liu, H., Jiang, J., Guo, Y., Xiao, J., & Wu, B. (2023). Hepatitis B virus X protein induces ALDH2 ubiquitin-dependent degradation to enhance alcoholic steatohepatitis. Gastroenterology Report, 11, goad006.","journal-title":"Gastroenterology Report"},{"issue":"2","key":"9923_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tplants.2020.09.004","volume":"26","author":"B Li","year":"2021","unstructured":"Li, B., Sun, C., Lin, X., & Busch, W. (2021). The emerging role of GSNOR in oxidative stress regulation. Trends in Plant Science, 26(2), 156\u2013168.","journal-title":"Trends in Plant Science"},{"issue":"2","key":"9923_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1530-0277.2008.00827.x","volume":"33","author":"V Purohit","year":"2009","unstructured":"Purohit, V., Gao, B., & Song, B. J. (2009). Molecular mechanisms of alcoholic fatty liver. Alcoholism: Clinical and Experimental Research, 33(2), 191\u2013205.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"9923_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.redox.2017.11.005","volume":"14","author":"L Hao","year":"2018","unstructured":"Hao, L., Sun, Q., Zhong, W., Zhang, W., Sun, X., & Zhou, Z. (2018). Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease. Redox Biology, 14, 626\u2013636.","journal-title":"Redox Biology"},{"issue":"2","key":"9923_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nsmb.1737","volume":"17","author":"S Perez-Miller","year":"2010","unstructured":"Perez-Miller, S., Younus, H., Vanam, R., Chen, C. H., Mochly-Rosen, D., & Hurley, T. D. (2010). Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nature Structural & Molecular Biology, 17(2), 159\u2013164.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"9923_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen, C. H., Ferreira, J. C., Gross, E. R., & Mochly-Rosen, D. (2014). Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiological Reviews, 94(1), 1\u201334.","journal-title":"Physiological Reviews"},{"issue":"34","key":"9923_CR40","doi-asserted-by":"publisher","first-page":"30550","DOI":"10.1074\/jbc.M502345200","volume":"280","author":"HN Larson","year":"2005","unstructured":"Larson, H. N., Weiner, H., & Hurley, T. D. (2005). Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase \u201cAsian\u201d variant. Journal of Biological Chemistry, 280(34), 30550\u201330556.","journal-title":"Journal of Biological Chemistry"},{"issue":"17","key":"9923_CR41","doi-asserted-by":"publisher","first-page":"12940","DOI":"10.1074\/jbc.M607959200","volume":"282","author":"HN Larson","year":"2007","unstructured":"Larson, H. N., Zhou, J., Chen, Z., Stamler, J. S., Weiner, H., & Hurley, T. D. (2007). Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. Journal of Biological Chemistry, 282(17), 12940\u201312950.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"9923_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cvr\/cvq192","volume":"88","author":"CH Chen","year":"2010","unstructured":"Chen, C. H., Sun, L., & Mochly-Rosen, D. (2010). Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovascular Research, 88(1), 51\u201357.","journal-title":"Cardiovascular Research"},{"issue":"13","key":"9923_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.116.021618","volume":"134","author":"C Woods","year":"2016","unstructured":"Woods, C., Shang, C., Taghavi, F., Downey, P., Zalewski, A., Rubio, G. R., Liu, J., Homburger, J. R., Grunwald, Z., Qi, W., Bollensdorff, C., Thanaporn, P., Ali, A., Riemer, K., Kohl, P., Mochly-Rosen, D., Gerstenfeld, E., Large, S., Ali, Z., & Ashley, E. (2016). In vivo post-cardiac arrest myocardial dysfunction Is supported by Ca2+\/calmodulin-dependent protein kinase ii-mediated calcium long-term potentiation and mitigated by Alda-1, an agonist of aldehyde dehydrogenase type 2. Circulation, 134(13), 961\u2013977.","journal-title":"Circulation"},{"issue":"4","key":"9923_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/cvr\/cvu125","volume":"103","author":"KM Gomes","year":"2014","unstructured":"Gomes, K. M., Campos, J. C., Bechara, L. R., Queliconi, B., Lima, V. M., Disatnik, M. H., Magno, P., Chen, C. H., Brum, P. C., Kowaltowski, A. J., Mochly-Rosen, D., & Ferreira, J. C. (2014). Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. Cardiovascular Research, 103(4), 498\u2013508.","journal-title":"Cardiovascular Research"},{"issue":"6","key":"9923_CR45","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.bbadis.2019.03.015","volume":"1865","author":"J Pang","year":"2019","unstructured":"Pang, J., Peng, H., Wang, S., Xu, X., Xu, F., Wang, Q., Chen, Y., Barton, L. A., Chen, Y., Zhang, Y., & Ren, J. (2019). Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease, 1865(6), 1627\u20131641.","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease"},{"issue":"7","key":"9923_CR46","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1096\/fj.201902550RRR","volume":"34","author":"SH Tsai","year":"2020","unstructured":"Tsai, S. H., Hsu, L. A., Tsai, H. Y., Yeh, Y. H., Lu, C. Y., Chen, P. C., Wang, J. C., Chiu, Y. L., Lin, C. Y., & Hsu, Y. J. (2020). Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells. The FASEB Journal, 34(7), 9498\u20139511.","journal-title":"The FASEB Journal"},{"issue":"6","key":"9923_CR47","doi-asserted-by":"publisher","first-page":"e001329","DOI":"10.1161\/JAHA.114.001329","volume":"3","author":"A Stachowicz","year":"2014","unstructured":"Stachowicz, A., Olszanecki, R., Suski, M., Wisniewska, A., Toton-Zuranska, J., Madej, J., Jawien, J., Bialas, M., Okon, K., Gajda, M., Glombik, K., Basta-Kaim, A., & Korbut, R. (2014). Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. Journal of the American Heart Association, 3(6), e001329.","journal-title":"Journal of the American Heart Association"},{"issue":"4","key":"9923_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/FJC.0000000000000655","volume":"73","author":"Q Yuan","year":"2019","unstructured":"Yuan, Q., Cao, S., Dong, Q., Wang, Z., Xu, Y., Han, Q., Ma, J., Wei, S., Pang, J., Yang, F., Zhang, R., Liu, B., Dai, S., Xue, L., Wang, J., Xue, M., Xu, T., Zheng, W., Xu, F., \u2026 Guo, P. (2019). ALDH2 Activation inhibited cardiac fibroblast-to-myofibroblast transformation via the TGF-beta1\/smad signaling pathway. Journal of Cardiovascular Pharmacology, 73(4), 248\u2013256.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9923_CR49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2019.10.416","volume":"146","author":"P Kang","year":"2020","unstructured":"Kang, P., Wang, J., Fang, D., Fang, T., Yu, Y., Zhang, W., Shen, L., Li, Z., Wang, H., Ye, H., & Gao, Q. (2020). Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis. Free Radical Biology and Medicine, 146, 198\u2013210.","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"9923_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbadis.2014.05.017","volume":"1852","author":"Y Guo","year":"2015","unstructured":"Guo, Y., Yu, W., Sun, D., Wang, J., Li, C., Zhang, R., Babcock, S. A., Li, Y., Liu, M., Ma, M., Shen, M., Zeng, C., Li, N., He, W., Zou, Q., Zhang, Y., & Wang, H. (2015). A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy. Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease, 1852(2), 319\u2013331.","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease"},{"issue":"9","key":"9923_CR51","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.freeradbiomed.2011.08.002","volume":"51","author":"W Ge","year":"2011","unstructured":"Ge, W., Guo, R., & Ren, J. (2011). AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Free Radical Biology and Medicine, 51(9), 1736\u20131748.","journal-title":"Free Radical Biology and Medicine"},{"issue":"15","key":"9923_CR52","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2174\/1389450116666150727115118","volume":"18","author":"R Zhang","year":"2017","unstructured":"Zhang, R., Wang, J., Xue, M., Xu, F., & Chen, Y. (2017). ALDH2\u2013-The genetic polymorphism and enzymatic activity regulation: their epidemiologic and clinical implications. Current Drug Targets, 18(15), 1810\u20131816.","journal-title":"Current Drug Targets"},{"issue":"4","key":"9923_CR53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.yjmcc.2009.10.030","volume":"48","author":"GR Budas","year":"2010","unstructured":"Budas, G. R., Disatnik, M. H., Chen, C. H., & Mochly-Rosen, D. (2010). Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. Journal of Molecular and Cellular Cardiology, 48(4), 757\u2013764.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"9923_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbrc.2019.03.037","volume":"512","author":"L Xue","year":"2019","unstructured":"Xue, L., Zhu, W., Yang, F., Dai, S., Han, Z., Xu, F., Guo, P., & Chen, Y. (2019). Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2. Biochemical and Biophysical Research Communications, 512(2), 319\u2013325.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9923_CR55","doi-asserted-by":"publisher","first-page":"108666","DOI":"10.1016\/j.pharmthera.2024.108666","volume":"259","author":"RJ Lamb","year":"2024","unstructured":"Lamb, R. J., Griffiths, K., Lip, G. Y. H., Sorokin, V., Frenneaux, M. P., Feelisch, M., & Madhani, M. (2024). ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation. Pharmacology & therapeutics, 259, 108666.","journal-title":"Pharmacology & therapeutics"},{"key":"9923_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2022.12.097","volume":"195","author":"X Tan","year":"2023","unstructured":"Tan, X., Chen, Y. F., Zou, S. Y., Wang, W. J., Zhang, N. N., Sun, Z. Y., Xian, W., Li, X. R., Tang, B., Wang, H. J., Gao, Q., & Kang, P. F. (2023). ALDH2 attenuates ischemia and reperfusion injury through regulation of mitochondrial fusion and fission by PI3K\/AKT\/mTOR pathway in diabetic cardiomyopathy. Free Radical Biology and Medicine, 195, 219\u2013230.","journal-title":"Free Radical Biology and Medicine"},{"key":"9923_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.alcohol.2024.03.010","volume":"117","author":"AJ Kwon","year":"2024","unstructured":"Kwon, A. J., Morales, L., Chatagnier, L., Quigley, J., Pascua, J., Pinkowski, N., Brasser, S. M., & Hong, M. Y. (2024). Effects of moderate ethanol exposure on risk factors for cardiovascular disease and colorectal cancer in adult Wistar rats. Alcohol, 117, 55\u201363.","journal-title":"Alcohol"},{"key":"9923_CR58","doi-asserted-by":"publisher","first-page":"128045","DOI":"10.1016\/j.bmcl.2021.128045","volume":"43","author":"L Chen","year":"2021","unstructured":"Chen, L., Wu, Y. T., Gu, X. Y., Xie, L. P., Fan, H. J., Tan, Z. B., Zhang, W. T., Chen, H. M., Li, J., Huang, G. Q., Liu, B., Zhou, Y. C., & Sun, X. M. (2021). Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts. Bioorganic & Medicinal Chemistry Letters, 43, 128045.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"3","key":"9923_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/1440-1681.12876","volume":"45","author":"WB Jiang","year":"2018","unstructured":"Jiang, W. B., Zhao, W., Chen, H., Wu, Y. Y., Wang, Y., Fu, G. S., & Yang, X. J. (2018). Baicalin protects H9c2 cardiomyocytes against hypoxia\/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clinical and Experimental Pharmacology and Physiology, 45(3), 303\u2013311.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"3","key":"9923_CR60","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/antiox10030450","volume":"10","author":"HL Lee","year":"2021","unstructured":"Lee, H. L., Hee, S. W., Hsuan, C. F., Yang, W., Huang, J. Y., Lin, Y. L., Hsu, C. N., Hwang, J. J., Chen, S. M., Ding, Z. Z., Lee, T. Y., Lin, Y. C., Tsai, F. C., Su, W. L., Chueh, L. Y., Hsieh, M. L., Chen, C. H., Mochly-Rosen, D., Chang, Y. C., & Chuang, L. M. (2021). A novel ALDH2 activator AD-9308 improves diastolic and systolic myocardial functions in streptozotocin-induced diabetic mice. Antioxidants (Basel), 10(3), 450.","journal-title":"Antioxidants (Basel)"},{"key":"9923_CR61","doi-asserted-by":"publisher","first-page":"111287","DOI":"10.1016\/j.cellsig.2024.111287","volume":"121","author":"ZM Cao","year":"2024","unstructured":"Cao, Z. M., Fu, S., Dong, C., Yang, T. Y., Liu, X. K., Zhang, C. L., & Li, D. Z. (2024). DSCR1-1 attenuates osteoarthritis-associated chondrocyte injury by regulating the CREB1\/ALDH2\/Wnt\/\u03b2-catenin axis: An in vitro and in vivo study. Cellular Signalling, 121, 111287.","journal-title":"Cellular Signalling"},{"issue":"4","key":"9923_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCRESAHA.123.323428","volume":"134","author":"X Nie","year":"2024","unstructured":"Nie, X., Fan, J., Dai, B., Wen, Z., Li, H., Chen, C., & Wang, D. W. (2024). LncRNA CHKB-DT downregulation enhances dilated cardiomyopathy through ALDH2. Circulation Research, 134(4), 425\u2013441.","journal-title":"Circulation Research"},{"key":"9923_CR63","doi-asserted-by":"publisher","first-page":"1147301","DOI":"10.3389\/fmolb.2023.1147301","volume":"10","author":"W Lee","year":"2023","unstructured":"Lee, W., & Kim, S. J. (2023). Protective effects of isoflavones on alcoholic liver diseases: Computational approaches to investigate the inhibition of ALDH2 with isoflavone analogues. Frontiers in Molecular Biosciences, 10, 1147301.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"15","key":"9923_CR64","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1021\/jm800488j","volume":"51","author":"ED Lowe","year":"2008","unstructured":"Lowe, E. D., Gao, G. Y., Johnson, L. N., & Keung, W. M. (2008). Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. Journal of Medicinal Chemistry, 51(15), 4482\u20134487.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"8","key":"9923_CR65","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.biopha.2009.12.001","volume":"65","author":"P Zhang","year":"2011","unstructured":"Zhang, P., Xu, D., Wang, S., Fu, H., Wang, K., Zou, Y., Sun, A., & Ge, J. (2011). Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway. Biomedicine & Pharmacotherapy, 65(8), 590\u2013593.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"9923_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012). Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacological Reviews, 64(3), 520\u2013539.","journal-title":"Pharmacological Reviews"},{"key":"9923_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2014.10.140","volume":"179","author":"KM Gomes","year":"2015","unstructured":"Gomes, K. M., Bechara, L. R., Lima, V. M., Ribeiro, M. A., Campos, J. C., Dourado, P. M., Kowaltowski, A. J., Mochly-Rosen, D., & Ferreira, J. C. (2015). Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. International Journal of Cardiology, 179, 129\u2013138.","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"9923_CR68","doi-asserted-by":"publisher","first-page":"921","DOI":"10.7150\/ijbs.42300","volume":"16","author":"W Wang","year":"2020","unstructured":"Wang, W., Wang, C., Xu, H., & Gao, Y. (2020). Aldehyde dehydrogenase, liver disease and cancer. International Journal of Biological Sciences, 16(6), 921\u2013934.","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"9923_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1021\/tx0501839","volume":"19","author":"JA Doorn","year":"2006","unstructured":"Doorn, J. A., Hurley, T. D., & Petersen, D. R. (2006). Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chemical Research in Toxicology, 19(1), 102\u2013110.","journal-title":"Chemical Research in Toxicology"},{"issue":"9","key":"9923_CR70","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.1021\/acsomega.2c00032","volume":"7","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Qiu, Y., & Zhang, H. (2022). Computational investigation of structural basis for enhanced binding of isoflavone analogues with mitochondrial aldehyde dehydrogenase. ACS Omega, 7(9), 8115\u20138127.","journal-title":"ACS Omega"},{"issue":"2","key":"9923_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/bjp.2008.263","volume":"155","author":"B Mayer","year":"2008","unstructured":"Mayer, B., & Beretta, M. (2008). The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. British Journal of Pharmacology, 155(2), 170\u2013184.","journal-title":"British Journal of Pharmacology"},{"issue":"48","key":"9923_CR72","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1073\/pnas.0406075101","volume":"101","author":"DR Janero","year":"2004","unstructured":"Janero, D. R., Bryan, N. S., Saijo, F., Dhawan, V., Schwalb, D. J., Warren, M. C., & Feelisch, M. (2004). Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proceedings of the National Academy of Sciences, 101(48), 16958\u201316963.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"34","key":"9923_CR73","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/eurheartj\/eht249","volume":"34","author":"T Munzel","year":"2013","unstructured":"Munzel, T., Daiber, A., & Gori, T. (2013). More answers to the still unresolved question of nitrate tolerance. European Heart Journal, 34(34), 2666\u20132673.","journal-title":"European Heart Journal"},{"key":"9923_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cbi.2017.03.012","volume":"276","author":"T Miura","year":"2017","unstructured":"Miura, T., Nishinaka, T., Terada, T., & Yonezawa, K. (2017). Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes. Chemico-Biological Interactions, 276, 40\u201345.","journal-title":"Chemico-Biological Interactions"},{"issue":"4","key":"9923_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2008.04.019","volume":"52","author":"T Gori","year":"2008","unstructured":"Gori, T., & Parker, J. D. (2008). Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. Journal of the American College of Cardiology, 52(4), 251\u2013254.","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"9923_CR76","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1073\/pnas.122225199","volume":"99","author":"Z Chen","year":"2002","unstructured":"Chen, Z., Zhang, J., & Stamler, J. S. (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proceedings of the National Academy of Sciences U S A, 99(12), 8306\u20138311.","journal-title":"Proceedings of the National Academy of Sciences U S A"},{"issue":"45","key":"9923_CR77","doi-asserted-by":"publisher","first-page":"30735","DOI":"10.1074\/jbc.M804001200","volume":"283","author":"M Beretta","year":"2008","unstructured":"Beretta, M., Sottler, A., Schmidt, K., Mayer, B., & Gorren, A. C. (2008). Partially irreversible inactivation of mitochondrial aldehyde dehydrogenase by nitroglycerin. Journal of Biological Chemistry, 283(45), 30735\u201330744.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"9923_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1253\/circj.CJ-11-1133","volume":"76","author":"JC Ferreira","year":"2012","unstructured":"Ferreira, J. C., & Mochly-Rosen, D. (2012). Nitroglycerin use in myocardial infarction patients. Circulation Journal, 76(1), 15\u201321.","journal-title":"Circulation Journal"},{"issue":"3","key":"9923_CR79","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1172\/JCI200419267","volume":"113","author":"K Sydow","year":"2004","unstructured":"Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mulsch, A., Schulz, E., Keaney, J. F., Jr., Stamler, J. S., & Munzel, T. (2004). Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. Journal of Clinical Investigation, 113(3), 482\u2013489.","journal-title":"Journal of Clinical Investigation"},{"issue":"23","key":"9923_CR80","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.jacc.2007.08.031","volume":"50","author":"U Hink","year":"2007","unstructured":"Hink, U., Daiber, A., Kayhan, N., Trischler, J., Kraatz, C., Oelze, M., Mollnau, H., Wenzel, P., Vahl, C. F., Ho, K. K., Weiner, H., & Munzel, T. (2007). Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. Journal of the American College of Cardiology, 50(23), 2226\u20132232.","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"9923_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00395-013-0343-3","volume":"108","author":"H Contractor","year":"2013","unstructured":"Contractor, H., St\u00f8ttrup, N. B., Cunnington, C., Manlhiot, C., Diesch, J., Ormerod, J. O., Jensen, R., B\u00f8tker, H. E., Redington, A., Schmidt, M. R., Ashrafian, H., & Kharbanda, R. K. (2013). Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models. Basic Research in Cardiology, 108(3), 343.","journal-title":"Basic Research in Cardiology"},{"issue":"2","key":"9923_CR82","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/molecules27020480","volume":"27","author":"Z Omran","year":"2022","unstructured":"Omran, Z. (2022). Novel disulfiram derivatives as ALDH1a1-selective inhibitors. Molecules, 27(2), 480.","journal-title":"Molecules"},{"issue":"5","key":"9923_CR83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0006-2952(00)00586-4","volume":"61","author":"ML Shen","year":"2001","unstructured":"Shen, M. L., Johnson, K. L., Mays, D. C., Lipsky, J. J., & Naylor, S. (2001). Determination of in vivo adducts of disulfiram with mitochondrial aldehyde dehydrogenase. Biochemical Pharmacology, 61(5), 537\u2013545.","journal-title":"Biochemical Pharmacology"},{"key":"9923_CR84","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fphar.2018.01161","volume":"9","author":"L Lu","year":"2018","unstructured":"Lu, L., Sun, X., Chen, C., Qin, Y., & Guo, X. (2018). Shexiang baoxin pill, derived from the traditional chinese medicine, provides protective roles against cardiovascular diseases. Frontiers in Pharmacology, 9, 1161.","journal-title":"Frontiers in Pharmacology"},{"issue":"51","key":"9923_CR85","doi-asserted-by":"publisher","first-page":"e13580","DOI":"10.1097\/MD.0000000000013580","volume":"97","author":"J Wen","year":"2018","unstructured":"Wen, J., Ma, X., Zhang, L., Lu, X., Yang, Y., Wang, J., & Zhao, Y. (2018). Therapeutic efficacy and safety of Shexiang Baoxin pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis. Medicine (Baltimore), 97(51), e13580.","journal-title":"Medicine (Baltimore)"},{"key":"9923_CR86","doi-asserted-by":"publisher","first-page":"46958019886958","DOI":"10.1177\/0046958019886958","volume":"56","author":"Q Wang","year":"2019","unstructured":"Wang, Q., Zhang, S., Wang, Y., Zhang, X., & Zhang, Y. (2019). Factors associated with hospitalization costs of coronary heart disease in township hospitals in Rural China. Inquiry, 56, 46958019886958.","journal-title":"Inquiry"},{"issue":"3","key":"9923_CR87","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0000000000000967","volume":"77","author":"J Hu","year":"2021","unstructured":"Hu, J., Zhao, Y., Wu, Y., Yang, K., Hu, K., Sun, A., & Ge, J. (2021). Shexiang baoxin pill attenuates ischemic injury by promoting angiogenesis by activation of aldehyde dehydrogenase 2. Journal of Cardiovascular Pharmacology, 77(3), 408\u2013417.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"9923_CR88","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1074\/jbc.M606477200","volume":"82","author":"P Wenzel","year":"2007","unstructured":"Wenzel, P., Hink, U., Oelze, M., Schuppan, S., Schaeuble, K., Schildknecht, S., Ho, K. K., Weiner, H., Bachschmid, M., Munzel, T., & Daiber, A. (2007). Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Journal of Biological Chemistry, 82(1), 792\u2013799.","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"9923_CR89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41419-020-02805-2","volume":"11","author":"W Li","year":"2020","unstructured":"Li, W., Yin, L., Sun, X., Wu, J., Dong, Z., Hu, K., Sun, A., & Ge, J. (2020). Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Disease, 11(7), 599.","journal-title":"Cell Death Disease"},{"issue":"1\u20133","key":"9923_CR90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2011.12.042","volume":"678","author":"L He","year":"2012","unstructured":"He, L., Liu, B., Dai, Z., Zhang, H. F., Zhang, Y. S., Luo, X. J., Ma, Q. L., & Peng, J. (2012). Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. European Journal of Pharmacology, 678(1\u20133), 32\u201338.","journal-title":"European Journal of Pharmacology"},{"key":"9923_CR91","doi-asserted-by":"publisher","first-page":"115146","DOI":"10.1016\/j.jep.2022.115146","volume":"292","author":"YN Cao","year":"2022","unstructured":"Cao, Y. N., Yue, S. S., Wang, A. Y., Xu, L., Hu, Y. T., Qiao, X., Wu, T. Y., Ye, M., Wu, Y. C., & Qi, R. (2022). Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity. Journal of Ethnopharmacology, 292, 115146.","journal-title":"Journal of Ethnopharmacology"},{"key":"9923_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.abb.2019.01.012","volume":"663","author":"T Kitakaze","year":"2019","unstructured":"Kitakaze, T., Makiyama, A., Samukawa, Y., Jiang, S., Yamashita, Y., & Ashida, H. (2019). A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1\/2 signaling pathway in HepG2 cells. Archives of Biochemistry and Biophysics, 663, 151\u2013159.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9923_CR93","doi-asserted-by":"publisher","first-page":"116000","DOI":"10.1016\/j.biopha.2023.116000","volume":"170","author":"L Qian","year":"2024","unstructured":"Qian, L., Xu, H., Yuan, R., Yun, W., & Ma, Y. (2024). Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction. Biomedicine & Pharmacotherapy, 170, 116000.","journal-title":"Biomedicine & Pharmacotherapy"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-024-09923-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:06:08Z","timestamp":1731546368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-024-09923-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":93,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9923"],"URL":"https:\/\/doi.org\/10.1007\/s12012-024-09923-9","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}